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1INTRODUCTION
The Wnt–GSK3–b-catenin pathway is central to pro-
esses at many stages of development and is highly con-
erved between species (Wodarz and Nusse, 1998). It is a
omplex pathway with branching outputs and alternative
nputs at almost every step (Arias et al., 1999) and it
therefore touches on many other regulatory systems. These
features of Wnt–GSK–b-catenin signaling perhaps reflect
ow ancient this pathway is evolutionarily (Gerhart, 1999),
llowing time for the signaling apparatus to accrete addi-
ions and variations. Its inappropriate activation is also
linically important in many cancers (Polakis et al., 1999).
Glycogen synthase kinase 3 (GSK3) is a central enzyme in
his pathway. It was originally identified as a serine/
hreonine kinase involved in the regulation of glycogen by
nsulin (Woodgett, 1990; Welsh and Proud, 1993) and is now
mplicated in many different biological processes including
umorigenesis, cell survival, and developmental patterning
Fig. 1). Some of its roles in development were recently
eviewed in this journal (Ferkey and Kimelman, 2000).
SK3 is involved in a number of quite distinct signal
ransduction pathways with different inputs and outputs
e.g., Hunter, 1997). Thus, an intriguing and important
uestion is how cross talk between these pathways is
revented. Recent progress in studies of Wnt signaling has
uggested some possible answers to this question. However,
he mechanism by which Wnt actually regulates GSK3 is
till unknown. In this regard, it is the questions that are just
eginning to emerge.
Wnt SIGNALING TO THE b-CATENIN
ESTRUCTION COMPLEX
It was experiments in Drosophila melanogaster that
identified GSK3 as a key regulator during the patterning of
the embryo (reviewed in Plyte et al., 1992; Woodgett, 1994).
A Drosophila homolog of GSK3 (shaggy, zeste-white 3) was
shown genetically to be essential in the wingless signal
transduction pathway together with two other components:
the novel Dishevelled (Dsh) protein and the cell adhesion
protein b-catenin (Armadillo) (Noordermeer et al., 1994; b
0012-1606/01 $35.00
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All rights of reproduction in any form reserved.Siegfried et al., 1994). Further studies in a number of species
led not only to formulation of a simple linear transduction
pathway known as the canonical Wnt pathway (Fig. 2) but
also to identification of noncanonical pathways initiated by
Wnt (beyond the scope of this review).
The canonical pathway was initially elucidated as a
genetic epistasis hierarchy, although biochemical detail has
emerged over the past few years (see the excellent review by
Seidensticker and Behrens, 2000). Some of the salient
events in Wnt signaling are depicted in Fig. 3. GSK3 is
active in resting cells and phosphorylates b-catenin. Phos-
phorylated b-catenin is ubiquitinated and degraded by the
proteasome. Low levels of cytoplasmic b-catenin constitute
he “off state” of the pathway. Upon Wnt stimulation (the
on state” of the pathway), GSK3 phosphorylation of
b-catenin is somehow downregulated. This promotes
b-catenin enrichment in the cytosol and nucleus, where it
binds to TCF/LEF transcription factors to upregulate tran-
scription of target genes. Several interesting targets of
b-catenin transcriptional activation have been identified.
Among these are the Drosophila segment polarity gene
engrailed (Siegfried et al., 1994; van de Wetering et al.,
997), the Xenopus Organizer gene siamois (Brannon and
imelman, 1996; Carnac et al., 1996; Nelson and Gum-
iner, 1998), and the mammalian cell cycle gene cyclin D
Shtutman et al., 1999). Point mutations in b-catenin that
liminate the putative GSK3-phosphorylatable sites are
ufficient to stabilize b-catenin in cells and thus lock in an
on state” (Munemitsu et al., 1996; Yost et al., 1996; Aberle
et al., 1997; Orford et al., 1997). These mutations have been
found in different types of cancers and are strongly corre-
lated with elevated cytoplasmic and nuclear b-catenin in
ivo (see Peifer and Polakis, 2000; Polakis, 2000).
Although GSK3 can phosphorylate b-catenin directly
(Yost et al., 1996), this phosphorylation is much more
efficient in the presence of so-called scaffolding proteins,
axin (Hart et al., 1998; Ikeda et al., 1998) or close relatives,
axil (Yamamoto et al., 1998) and conductin (Behrens et al.,
1998). These proteins bridge GSK3 to b-catenin. The pro-
ein APC (adenomatous polyposis coli) protein may also
erve a bridging role (Munemitsu et al., 1995; Hart et al.,
998; Kawahara et al., 2000). The axin-bridged complex has
een called the b-catenin destruction complex.
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304 Dominguez and GreenAssembly of a protein complex is an appealing mecha-
nism to explain limited cross talk between different GSK3
regulators: within the b-catenin destruction complex,
SK3 would be affected by Wnt signals and not by other
egulators of GSK3 activity. Outside the complex, GSK3
ould have no effect on b-catenin. Thus, participation in
his and, alternatively, other complexes would enable GSK3
o populate different pools that would be differentially
esponsive to the different signals and give different out-
uts. For example, although both insulin and the secreted
gonist Wnt both decrease total cellular GSK3 activity,
nsulin does not increase cytoplasmic levels of b-catenin
protein, whereas Wnt does not alter glycogen synthase
activity (Ding et al., 2000).
Two types of mechanisms have been proposed for the
regulation by Wnt of the b-catenin destruction complex.
he first invokes changes in the subunit composition or
rrangement of the destruction complex. The second in-
olves reduction of GSK3 intrinsic enzymatic activity. To
hese might be added a third mechanism, destabilization of
he GSK3 protein. Each of these models offers advantages
or interpretation of data in the literature. Fortunately, they
re not mutually exclusive and in reviewing each below we
an begin to see a synthesis and integration of the three
odels.
STERIC HINDRANCE OF GSK3
Given that GSK3 acts on b-catenin in a multiprotein
complex and that outside this complex b-catenin is poorly
phosphorylated, it is reasonable to suppose that complex
FIG. 1. GSK3 in different transduction pathways. Glycogen syn-
thase kinase 3 (GSK3) is a serine threonine kinase at the core of
several distinct signal transduction pathways that are implicated in
many different biological processes including tumorigenesis, cell
survival, and developmental patterning. Questions surrounding the
transduction pathways involved and how cross talk between these
pathways is prevented are reviewed in the text. EGF 5 epidermal
growth factor.assembly and disassembly may be a critical regulatory
Copyright © 2001 by Academic Press. All rightmechanism. The lack of obvious enzymatic domains of Dsh
and the presence of potential protein–protein interaction
motifs (known as DIX and PDZ) also hint that regulation of
protein interactions might be its mechanism of action in
transducing a Wnt signal to GSK3. A number of similar
scenarios have been proposed or implied in the literature to
describe what Dsh does to the GSK3–Axin–b-catenin com-
plex in response to a Wnt signal. These scenarios suggest
that Wnt-activated Dishevelled binds to Axin and thereby
displaces GSK3 from it (Fig. 3, arrow X, and Fig. 4B). This
scenario is based on, among other observations, the follow-
ing two results. First, overexpressed Dishevelled co-
immunoprecipitates with Axin, and the Dishevelled–Axin
interaction (DIX) domain (present in both proteins) is essen-
tial for the effect of Dishevelled on the complex (Fagotto et
al., 1999; Kishida et al., 1999; Li et al., 1999; Smalley et al.,
999; Itoh et al., 2000; Salic et al., 2000). Second, Dishev-
lled can displace GSK3 from a complex of b-catenin and
Axin-Related Protein in mammalian cells and Xenopus
embryos (Itoh et al., 2000). This dissociation would prevent
GSK3 from efficiently phosphorylating b-catenin. The dis-
sociation of GSK3 from axin is also induced by wingless/
Wnt (Li et al., 1999; Ruel et al., 1999). This suggests that
FIG. 2. The linear Wnt-b-catenin pathway. The identification and
relative position of the first elements of the Wnt signal transduc-
tion pathway by epistasis experiments in Drosophila was quickly
followed by the identification of novel components. Wg 5 wing-
less. Dsh 5 Dishevelled; Zw3-sh 5 zeste-white 3-shaggy. TCF/
LEF 5 T-Cell Factor/Leukemia Enhancing Factor. Note that the
arrows reflect position only in the pathway and not necessarily
direct biochemical interactions. Mammalian homologs of Dro-
sophila proteins are in parentheses.
s of reproduction in any form reserved.
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305Missing Links in GSK3 RegulationWnt-activated Dsh inhibits the activity of the destruction
complex by dissociating GSK3 from it, thus preventing
efficient b-catenin phosphorylation.
A variation on the preceding model is that Wnt-activated
sh rearranges (and disables) but does not break up the
b-catenin destruction complex. In support of this model it
has been shown that Dishevelled does not prevent GSK3–
Axin binding in vitro (Kishida et al., 1999). Also, in re-
sponse to Wnt-1 expression, the amounts of GSK3 and APC
associated with b-catenin actually increase (Papkoff et al.,
1996; Papkoff and Aikawa, 1998). Furthermore, Willert et
al. (1999) found that the amount of GSK3 and b-catenin
mmunoprecipitated with axin did not change in response
o Wnt-3A signaling. This was despite reduced binding
ffinity between b-catenin and axin from Wnt-3A-treated
cells. The reduced binding affinity was correlated with
hypophosphorylation of axin, presumably a result of re-
FIG. 3. The “off” and “on” states of the Wnt-GSK3b-b-catenin pat
off state, GSK3 phosphorylates b-catenin, rendering it inactive for
inding with slimb/Trcp protein (not shown; see Marikawa and E
ccurs in a “destruction complex,” with Axin and/or APC br
phosphorylates Axin, enhancing its affinity for b-catenin. Target ge
998). (B) In the on state, the b-catenin destruction complex is
ransducing protein Dishevelled. The sequence of events that lead f
f the “activation,” and its action on the b-catenin destruction com
one way or another to downregulate GSK3 action. With GSK3 act
protein phosphatase 2A, not shown) and destabilized, whereas non
nter the nucleus. In the nucleus, b-catenin activates transcription
X, Y, and Z represent three possible points of regulation of GSK3.
destruction complex. Arrow Y: Dishevelled could recruit the GSK
activities. Arrow Z: modification of GSK3 protein, for example, by
See text and Fig. 4 for further details.duced access or activity of GSK3. m
Copyright © 2001 by Academic Press. All rightTaking the above-described data together, we are left
ith a model in which—in response to Wnt—GSK3, axin,
nd b-catenin remain loosely associated but without
b-catenin phosphorylation and destruction. In other words,
steric rearrangement of the complex in response to Wnt
would prevent effective catalytic activity. This would allow
de novo synthesized b-catenin to accumulate in the cyto-
lasm and nucleus.
This model of a loose, sterically inactivated complex is
onsistent with the recent discoveries concerning interac-
ion between axin and newly identified Wnt receptors.
ammalian lipoprotein–receptor-related proteins LRP5
nd LRP6 and a Drosophila homolog, Arrow protein, are
transmembrane Wnt receptors essential for Wnt signaling
(Tamai et al., 2000; Wehrli et al., 2000). In a very recent
tudy, Mao et al. (2001) showed that Wnt causes recruit-
ent of axin to the cytoplasmic domain of LRP5. Further-
. “P” indicates some likely significant phosphorylations. (A) In the
cription and targeting it for proteasome-dependent breakdown via
n, 1998; Kitagawa et al., 1999; Liu et al., 1999). Phosphorylation
g GSK3 to b-catenin to enhance phosphorylation. GSK3 also
re repressed by Groucho protein (Cavallo et al., 1998; Roose et al.,
regulated by Wnt via the frizzled receptor and the intracellular
Wnt binding to frizzled and “activation” of Dishevelled, the nature
are open questions. To upregulate b-catenin levels it is essential
reduced or absent, Axin becomes dephosphorylated (probably by
sphorylated b-catenin, which is more stable and active, is able to
arget genes with the help of TCF/LEF HMG-box proteins. Arrows
w X: Intrusion of Dishevelled protein could physically disrupt the
ding protein, GBP/FRAT that displaces and inhibits some GSK3
hevelled-dependent kinase, could reduce GSK3’s intrinsic activity.hway
trans
linso
idgin
nes a
down
rom
plex
ivity
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of t
Arro
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a Disore, this recruitment to the membrane is important for
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306 Dominguez and GreenLRP5-inducible stimulation of b-catenin signaling. This
ight suggest a version of the steric model in which the
ytoplasmic domain of LRP5 (persumably in concert with
ishevelled) effectively blocks b-catenin phosphorylation
by GSK3. This is likely to be within the axin–GSK3–b-
atenin destruction complex because GSK3 activity facili-
ates the axin–LRP5 interaction. It is significant that the
xin–LRP5 interaction is a very rapid (2–3 min) response to
nt stimulation and may thus represent the initiating
vent of receptor signal transduction.
INTRINSIC MODIFICATION OF GSK3
ACTIVITY
It has been repeatedly shown that Wnt stimulation of
cells causes reduction in the specific activity of GSK3
toward specific peptide substrates (Cook et al., 1996; Itoh et
l., 1998; Papkoff and Aikawa, 1998; Ruel et al., 1999; Ding
t al., 2000; Dominguez and Green, 2000). This decrease in
SK3 specific activity is correlated with upregulation of
FIG. 4. Three speculative models of GSK3 regulation. Note that t
phosphatases. (A) The off state of the pathway. In the absence of Wn
his targets it for degradation. (B–D) Molecular models for the on
nt, Dishevelled protein becomes activated and physically inte
hosphorylating Axin and b-catenin because conformation of the a
affinity for b-catenin is further reduced. b-catenin is released. Stab
xin, Dishevelled, and GSK3 may remain loosely associated. (
ransducing protein X modifies GSK3 protein (e.g., through phospho
ction of Dishevelled (indicated by a question mark). Axin beco
phosphorylated, b-catenin is thus stabilized and can enter the nuc
omplex where it binds to GSK3. This simultaneously inhibits
destabilization. This may or may not be a Wnt-dependent processb-catenin (Larabell et al., 1997; Papkoff and Aikawa, 1998). o
Copyright © 2001 by Academic Press. All rightImportantly, it occurs in cells that are otherwise unper-
turbed and therefore reflects physiological Wnt signal trans-
duction. A priori, this decrease could be attributed to
modification of either the b-catenin destruction complex or
he GSK3 protein itself. A number of studies address this
uestion by adding components of the b-catenin destruc-
tion complex to purified recombinant GSK3 (Ikeda et al.,
1998; Yamamoto et al., 1998, 1999; Yost et al., 1998;
Hedgepeth et al., 1999; Kishida et al., 1999; Thomas et al.,
1999; Farr et al., 2000). These studies showed that changing
the complex composition in vitro changes phosphorylation
activity toward axin and b-catenin substrates, supporting
he steric hindrance models described in the preceding
ection. However, none of them detected any effect on
eptide phosphorylation. Thus, the change in specific ac-
ivity toward peptide substrates in response to Wnt signal-
ng in vivo may instead be attributed to a change in the
ntrinsic activity of GSK3 itself (Fig. 3, arrow Z, and Fig.
C). Modification of GSK3 leading to a decrease in its
ntrinsic specific activity would be sufficient to explain an
ncrease in b-catenin stability, even without rearrangement
odels are not mutually exclusive and that all assume constitutive
atenin is phosphorylated by GSK3 within the destruction complex.
of the pathway. (B) Steric action of Dishevelled. Upon binding of
with the destruction complex. Thus, GSK3 is prevented from
ridged complex is altered. As Axin becomes dephosphorylated, its
b-catenin accumulates in the cytoplasm and enters the nucleus.
odification of GSK3. Upon binding of Wnt, some unidentified
ion), reducing its specific activity. Protein X somehow requires the
dephosphorylated and loses its affinity for b-catenin. No longer
(D) Destruction of GSK3. Dishevelled recruits FRAT/GBP to the
3 phosphorylation of Axin and b-catenin and marks GSK3 forhe m
t, b-c
state
rferes
xin-b
ilized
C) M
rylat
mes
leus.
GSKf the destruction complex.
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307Missing Links in GSK3 RegulationCould it be that Wnt causes modification of GSK3 pro-
tein? One possibility is that Wnt causes phosphorylation of
GSK3, but there are contradictory data in the literature on
this point. Ding and McCormick (2000) saw no change in
the phosphorylation state of GSK3 in mammalian cells
responding to Wnt exposure. However, Ruel et al. (1999)
overexpressed Dishevelled in Drosophila cell lines to
mimic a Wingless (Drosophila Wnt) signal and found that
inhibition of GSK3 activity was accompanied by increased
serine phosphorylation of the latter. This may reflect a
difference in the mechanism of transduction of extracellu-
lar Wnt used by Ding and McCormick (2000) versus over-
expressed Dishevelled used by Ruel et al. (1999), or could
eflect an apparently transient versus a sustained signal,
espectively.
There is a precedent for GSK3 activity reduction by
pecific phosphorylation of GSK3. In response to insulin
nd a number of growth factors, intrinsic GSK3-specific
ctivity is known to be reduced by phosphorylation of its
erine-9 residue (Sutherland et al., 1993; Welsh and Proud,
993; Saito et al., 1994; Welsh et al., 1994; Cross et al.,
995; Eldar-Finkelman et al., 1995). This serine is an
nhibitory target of kinases, Akt (PKB), p70-S6 kinase, and
90-rsk-1 in vitro (Sutherland et al., 1993; Saito et al., 1994;
tambolic and Woodgett, 1994; Cross et al., 1995). How-
ver, four sets of experiments show that these transducing
inases and serine-9 phosphorylation are not the targets of
nt signaling.
First, overexpression of these kinases does little to modu-
ate axis formation in Xenopus, a sensitive assay for Wnt
ctivity (Torres et al., 1999 and I. Dominguez, unpublished
bservations). Second, overexpression of either p90-rsk or
kt (PKB) has no detectable effect in upregulating free
b-catenin in Xenopus or mammalian cells (Torres et al.,
999; Yuan et al., 1999) or TCF/LEF activation (Yuan et al.,
999). Third, known inhibitors of the serine-9 phosphory-
ating pathways, rapamycin and wortmannin, have little
ffect on either Wnt-dependent GSK3 inhibition (Cook et
l., 1996) or early axis formation in Xenopus (I. Dominguez,
npublished observations). Fourth, and most directly, Ding
nd McCormick (2000) have shown that Wnt signaling and
nsulin signaling via serine-9 phosphorylation are distinct
ays of regulating GSK3 and that Wnt signaling does not
etectably alter the serine-9 phosphorylation state of GSK3.
onetheless, Akt (PKB) can contribute somewhat to the
agnitude of b-catenin-responsive reporter activation
Yuan et al., 1999) and a serine-9-to-alanine mutant in
SK3 can inhibit signaling more efficiently that wild type
SK3 (Smalley et al., 1999). These results suggest that
erine-9 phosphorylation can contribute to the downregu-
ation of GSK3 (perhaps by lowering its basal activity) but is
ot part of the Wnt signal as such.
There is some evidence that a phorbol ester-sensitive
soform of protein kinase C (PKC) might be involved in
nt–GSK3 signaling (Goode et al., 1992; Cook et al., 1996).
nhibitor studies suggested that PKC is required for Wnt
anonical signaling (Cook et al., 1996) but these results are s
Copyright © 2001 by Academic Press. All rightomplicated by the subsequent discovery that the same
nhibitors also inhibit GSK3 directly (Hers et al., 1999) and
ay thus have suppressed GSK3 responsiveness to Wnt in
he earlier study. Also, inhibitors of PKC do not completely
lock Wnt effects (Chen et al., 2000). There is good evi-
ence that some Wnts and Frizzleds do stimulate PKC
ctivity (Sheldahl et al., 1999). However, these Wnts and
rizzleds belong to the so-called nontransforming class that
o not use the canonical pathway. Nontransforming Wnt/
rizzled combinations do not affect b-catenin levels, are not
active in Xenopus axis induction assays, and probably
stimulate PKC activity via intracellular calcium release
(Sheldahl et al., 1999; Kuhl et al., 2000).
A kinase recently implicated in the Wnt signaling is
asein kinase I epsilon (CKIe). Based on dominant negative,
inhibitor, antisense, and RNA-interference assays (Peters et
al., 1999; Sakanaka et al., 1999), this kinase is absolutely
required for Wnt signaling. Although CKIe seems to be
upstream of GSK3, it neither phosphorylates GSK3 nor
binds to it (Peters et al., 1999; Sakanaka et al., 1999).
Intriguingly, CKIe can bind to both Dishevelled and Axin
and increases the level of phosphorylated Dishevelled (Pe-
ters et al., 1999; Sakanaka et al., 1999). However, it is not
known whether the activity of CKIe is altered by Wnt
stimulation or whether its effect on Dishevelled is required
for Dsh function. Another casein kinase, casein kinase II
(CK2), has also been implicated in Wnt signaling. CK2 RNA
and kinase levels increase in cells transfected with Wnt
(Song et al., 2000). Like CKIe, CK2 co-immunoprecipitates
ith and phosphorylates Dishevelled protein and has there-
ore been described as “Dishevelled kinase” (Willert et al.,
997; Song et al., 2000). CK2 also co-immunoprecipitates
ith and phosphorylates b-catenin, increasing its stability
(Song et al., 2000). CK2, b-catenin, and Dsh form a complex
from which GSK3 is absent (Song et al., 2000), which is
consistent with the steric models described above, but does
not explain regulation of intrinsic GSK3 activity.
ROLES OF THE GSK-BINDING PROTEIN
GBP/FRAT
A small (17-kDa) protein was identified as a GSK3-
binding protein (GBP) in a two-hybrid screen for GSK3-
interacting proteins in Xenopus (Yost et al., 1998). This
protein not only binds to GSK3 but also inhibits its activity
in oocyte assays and acts like Wnt in Xenopus axis-
ormation assays (Yost et al., 1998). Mammalian homologs
(or close relatives) of GBP were independently identified as
promoters of T-cell lymphomas in a mouse model of virally
induced tumors (Jonkers et al., 1997). The mammalian
genes were named FRAT1, -2, and -3 (for Frequently Rear-
ranged in Advanced T-cell lymphomas). FRATs show the
same axis-inducing activity as GBP in Xenopus axis-
nducing assays (Yost et al., 1998; Jonkers et al., 1999).
nterestingly, the effect of GBP/FRAT on GSK3 activity is
ubstrate specific, in that phosphorylation of axin and
s of reproduction in any form reserved.
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308 Dominguez and Greenb-catenin is reduced but phosphorylation of some other
substrates is not (Thomas et al., 1999; Farr et al., 2000). In
particular, phosphorylation of peptides used to assay GSK3
activity is not reduced by FRAT/GBP (Thomas et al., 1999;
Yuan et al., 1999; Dominguez and Green, 2000; Farr et al.,
2000). Such a substrate-specific inhibition is another way in
which cross talk between different GSK3 pathways may be
prevented.
As FRAT interacts with both GSK3 and Dishevelled (Li et
al., 1999) it has been proposed that Dishevelled recruits
FRAT to the b-catenin destruction complex (Li et al., 1999;
Salic et al., 2000) (in Fig. 3, arrow Y and Fig. 4D). Thus,
FRAT could pair with GSK3, whereas Dishevelled binds to
Axin. In support of this scenario, it has been shown that
GBP, FRAT, or a GSK3-binding fragment of FRAT can
dissociate GSK3 from the complex with Axin (Li et al.,
1999; Thomas et al., 1999; Yuan et al., 1999; Farr et al.,
2000). The requirement of FRAT/GBP for Wnt signaling is
still uncertain. On the one hand, a mutant of FRAT1 that
lacks a GSK-interaction site acts like a dominant-negative
mutation in the Wnt pathway (Li et al., 1999). This is
consistent with the notion that FRAT1 is a component of
the Wnt signaling. On the other hand, the amount of GSK3
co-immunoprecipitated with FRAT does not increase upon
Wnt stimulation (Li et al., 1999). This might indicate that
FRAT is not part of the Wnt signal at all or at least that its
regulation is subtle. A Wnt-independent role is consistent
with the absence of obvious GBP or FRAT homologs in the
Drosophila and C. elegans genome sequences.
An alternative role for GBP/FRAT may be to destabilize
GSK3 (Fig. 4D). Evidence for this comes from analysis of the
axis-formation process in Xenopus embryos. Depletion of
maternally stored mRNA encoding either GBP or b-catenin
esults in loss of dorsal development (Heasman et al., 1994;
ylie et al., 1996; Yost et al., 1998), indicating a require-
ment of both GBP and b-catenin for endogenous axis
ormation. Quantitative Western blotting and in situ im-
unofluorescence show a reduced concentration of endog-
nous GSK3 on the future dorsal side of the embryo,
ndicating a localized depletion of GSK3 protein
Dominguez and Green, 2000). This depletion is mimicked
y ectopic overexpression of GBP (Dominguez and Green,
000). This depletion of GSK3 protein appears to be inde-
endent of Wnt signaling because overexpression of either
nt or Dishevelled effectively stabilizes b-catenin and
nduces an axis but does not reduce GSK3 abundance
Dominguez and Green, 2000). This suggests that GBP may
e acting in a Wnt-independent manner in this system.
Because the Xenopus embryo is an often-used assay and
odel system, it is worth dwelling on whether Wnt-
ependent or Wnt-independent mechanisms are indeed the
hysiologically relevant ones. Although the requirement
or GBP in axis formation and its GSK3-depleting effect
ogether suggest a Wnt-independent mechanism of axis
ormation, there is also good evidence that Wnt signaling is
ndeed involved. Depletion of maternal mRNA encoding
he Wnt receptor Xenopus Frizzled-7 (Xfrz7) leads to loss of
Copyright © 2001 by Academic Press. All rightorsal character and loss of early dorsal gene expression
Sumanas et al., 2000). Furthermore, RNA for Xwnt11 is
nriched in polysomes (i.e., preferentially translated) on the
uture dorsal side (Schroeder et al., 1999). Because Xfrz7
ynergizes with Xwnt11 in axis-formation assays (Sumanas
t al., 2000), a plausible model is one in which dorsally
nriched Wnt signals through Xfrz7 to locally increase
b-catenin levels. Curiously, Xwnt11 is a poor axis inducer
when expressed ectopically on the ventral side of embryos
(Ku and Melton, 1993; Du et al., 1995) and it has been
classified as a nontransforming (i.e., non-b-catenin regulat-
ng) Wnt (Du et al., 1995; Kuhl et al., 2000).
A second maternally encoded Wnt, that is, Wnt5A, also
alls into this category (Du et al., 1995; Kuhl et al., 2000).
However, the above-mentioned Xwnt11/Xfrz7 synergy, a
similar effect with Xwnt5A, and previous similar experi-
ments with heterologous Frizzleds (He et al., 1997) all
indicate that the transforming/nontransforming distinction
may not be rigid. Thus, while in other assays Xwnt11 (and
Xwnt5A) may have little effect on b-catenin, the receptor
frz7 may transduce Xwnt11 (or Xwnt5A) signaling via the
anonical GSK–b-catenin pathway. If Xwnt11 is the signal
and Xfrz7 is its receptor, then why is ectopic Xwnt11 such
a poor axis inducer? Perhaps some other factor that is
limiting for Wnt signaling is enriched on the future dorsal
side of the embryo. A candidate for a dorsally enriched
Wnt-signal-limiting factor is Xenopus Dishevelled. By
Western blot and in situ immunofluorescence Dishevelled
appears enriched on the future dorsal side of the embryo
after cortical rotation (Miller et al., 1999). A plausible
model, then, is one in which both Xwnt11 and Dishevelled
are enriched on the prospective dorsal side and that the
former signals to the latter via Xfrz7.
The studies on endogenous GSK3 depletion and those
revealing the effects of experimentally induced frizzled
depletion both deserve special attention because, unlike
many previous experiments in Xenopus and mammalian
cells, they do not rely on nonphysiological overexpression
of exogenous genes. Yet, at first glance they might appear to
be contradictory, suggesting Wnt-independent and Wnt-
dependent signaling, respectively. There are a number of
ways to reconcile this apparent contradiction. One way is
with new models in which the two types of signal act at
different times. Given that the dorsal depletion of GSK3
protein is observed from fertilization to at least Stage 6
(Dominguez and Green, 2000), it may be that GBP-
dependent depletion precedes (and may provoke) subse-
quent Wnt signals. There are some hints of a transition to
Wnt signaling at the morula stage (NF Stage 6) consistent
with such a serial arrangement. At Stage 6, there is a
detectable shift in the phosphorylation state of Dishevelled,
which is correlated with Wnt signaling in controls (Roth-
bacher et al., 2000). Also at Stage 6 there is a marked
increase in the nuclear (versus cytoplasmic) enrichment of
b-catenin on the future dorsal side of the embryo (Schneider
et al., 1996; Larabell et al., 1997). How tightly coupled to
Wnt signaling the timing of this is has not been established
s of reproduction in any form reserved.
A
p
P
f
e
c
a
a
l
d
e
t
f
c
A
f
B
r
309Missing Links in GSK3 Regulationin controls or in other systems. Alternatively, endogenous
embryonic Wnt signaling may simply be unusual, involving
canonical pathway components but leading to GSK3 deple-
tion for reasons we do not yet understand.
AXIN AND APC
Whether GSK3 is removed from the b-catenin destruc-
tion complex, is rearranged within it, or has its intrinsic
activity reduced, subsequent dephosphorylation of Axin
may play an important role in reinforcing the change. Axin
regulation within the complex depends on GSK3. GSK3
phosphorylates axin (Ikeda et al., 1998; Yamamoto et al.,
1998; Jho et al., 1999; Willert et al., 1999) and axin phos-
phorylation by GSK3 increases axin’s affinity for b-catenin
in vivo and in vitro (Jho et al., 1999; Willert et al., 1999).
xin phosphorylation thus increases the ability of GSK3 to
hosphorylate and downregulate b-catenin. Under Wnt-3A
stimulation, Axin is dephosphorylated and thus its ability
to bridge is lowered (Willert et al., 1999). Axin dephosphor-
ylation also reduces its stability (Willert et al., 1999;
Yamamoto et al., 1999). Both these effects would make a
Wnt signal more switchlike because relatively modest
changes in the effective activity of GSK3 for Axin/b-catenin
phosphorylation would be dramatically enhanced by loss of
Axin bridging activity. Thus, phosphatase activity is impor-
tant in the Wnt pathway. Recently it was shown that the
protein phosphatase PP2A could be part of the destruction
complex. Axin binds PP2A-C, the catalytic subunit of the
protein phosphatase PP2A (Hsu et al., 1999; Fagotto et al.,
1999) and PP2A can dephosphorylate axin (Willert et al.,
1999; Strovel et al., 2000).
A recent study shows that PP2A might also act at the
level of the TCF transcription factor by conversion of
XTcf-3 from a repressor to an activator (Ratcliffe et al.,
2000). PP2A-B mutations have been observed in some colon
and lung tumors consistent with a role in tumor suppres-
sion (Wang et al., 1998). Furthermore, mice deficient in
P2A-C are embryonic lethal, suggesting an essential role
or this phosphatase during embryonic development (Gotz
t al., 1998). A similar phosphorylation–dephosphorylation
ycle may be important for APC participation in the
b-catenin destruction complex. GSK3 phosphorylates APC
in its central region (Rubinfeld et al., 1996; Hart et al., 1998)
nd this phosphorylation is facilitated by Axin (Rubinfeld et
l., 1996; Hart et al., 1998; Ikeda et al., 2000). Phosphory-
ated APC shows enhanced b-catenin binding to this central
region. A regulatory subunit of PP2A, PP2A-B9, interacts
with APC (Seeling et al., 1999) and PP2A can promote APC
dephosphorylation (Ikeda et al., 2000). The interaction of
APC with b-catenin and axin is required for APC to
ownregulate b-catenin (Kawahara et al., 2000). This inter-
action occurs through the central part of APC, the regions
where most APC mutations detected in tumors are found
(reviewed in Polakis, 1997). All these data suggest a positive
role for PP2A in Wnt signaling, although there is no
Copyright © 2001 by Academic Press. All rightvidence that Wnt regulates PP2A activity. This is consis-
ent with models in which continuous phosphatase action
acilitates or amplifies the regulation of other pathway
omponents.
Recent data have uncovered a role for APC in exporting
b-catenin from the nucleus. APC contains nuclear export
sequences that seem to be important in its tumor-
suppressing activity and reducing levels of nuclear
b-catenin (Henderson, 2000; Rosin-Arbesfeld et al., 2000).
However, this transport function is unlikely to be the only
role for APC, given that mutants lacking nuclear export
sequences are still able to reduce b-catenin levels (Rosin-
rbesfeld et al., 2000), perhaps because they retain bridging
unctions. Based on a variety of protein localization data,
ienz (1999) proposed that APC has a spatial regulatory
ole, shuttling b-catenin to degradation complexes associ-
ated with apical adhesive junctional zones of polarized
epithelial cells. APC is associated with dynamic microtu-
bules (Mimori-Kiyosue et al., 2000) and mitotic spindle
orientation (Korinek et al., 2000; Lee et al., 2000), and a
connection between these functions and Wnt signaling or
GSK3 activity may yet emerge.
OVERVIEW
Three modes of GSK3 regulation in the Wnt pathway
have been described: (1) physical displacement by Dishev-
elled; (2) reduction of intrinsic specific activity by protein
modification; and (3) protein degradation. The integrated
view of these is that they could all contribute to transduc-
tion of Wnt signals. Genetic mutations show that Dishev-
elled is required, while the rapid reduction of GSK3-specific
activity in response to Wnt (Ding et al., 2000) suggests that
it is a direct effect. A role for GBP/FRAT and protein
degradation in Wnt signaling is less clear. Of course, the
three difference mechanisms could operate on different
time scales or in different cell types. However, it is also
possible—and perhaps not always made obvious in the
literature—that all three mechanisms could operate in the
same cell at the same time in response to a single Wnt
signal.
Our understanding of the Wnt–GSK–b-catenin pathway
has gone through several identifiable stages. Drosophila
genetics identified many of the pathway components and
their relative positions in the pathway. Molecular identifi-
cation of the components by gene cloning illuminated
conserved pathways in mammalian systems and gave in-
sights into the function of some of the components based
on their structure. Protein-interaction studies identified
further components and characterized critical protein inter-
actions. Correlations with human tumors illuminated yet
additional structure–function relationships, and this is
where we are now. Two further developments are predict-
able. One is the elaboration of a more biochemical under-
standing of the actual Wnt-triggered signaling events. This
will no doubt require more detailed understanding of phos-
s of reproduction in any form reserved.
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overexpression studies to more physiological approaches
and identification of new signaling components.
A second predictable development is an appreciation of
species differences as well as their commonalities. Subtle
and not-so-subtle differences in the Wnt–GSK–b-catenin
pathway between species are already known. For example,
in C. elegans, loss of the nearest homolog to APC, APR-1,
imics loss of b-catenin (Rocheleau et al., 1997). This
suggests that APR-1 protein normally preserves rather than
helps destroy b-catenin as APC does in other species. The
ariations as well as the baroque complexity of this path-
ay continue to fascinate and tantalize. Perhaps tellingly,
he recently reported knockout of GSK3b in mouse (Hoe-
flich et al., 2000) was rather uninformative about Wnt–b-
catenin signaling. It produced surprisingly normal embryos
(at least until embryonic day 12.5). The knockout mice had
dysregulation of NF-k-b and excessive cell death indicative
of excess tumor necrosis factor toxicity. Surprisingly, there
was no evidence that Wnt signaling, cyclin D levels,
b-catenin accumulation, or glycogen metabolism were per-
turbed. Perhaps the GSK3-a isoform was compensating for
the loss of GSK3-b in Wnt signaling. Understanding the
complexity of GSK3 regulation is clearly going to require
more detailed analysis at every level from physiological to
biochemical and structural. In particular, it will require
identification of the missing links between Wnt arriving at
the cell surface and the resulting reduction of GSK3 activ-
ity.
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